Статті в журналах з теми "Protein-HIV Virus"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Protein-HIV Virus".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Travis, J. "HIV Protein Prepares Virus' Next Victims." Science News 152, no. 4 (July 26, 1997): 53. http://dx.doi.org/10.2307/3981058.
Повний текст джерелаRomani, Bizhan, and Susan Engelbrecht. "Human immunodeficiency virus type 1 Vpr: functions and molecular interactions." Journal of General Virology 90, no. 8 (August 1, 2009): 1795–805. http://dx.doi.org/10.1099/vir.0.011726-0.
Повний текст джерелаÁlvarez, Enrique, Alfredo Castelló, Luis Menéndez-Arias, and Luis Carrasco. "HIV protease cleaves poly(A)-binding protein." Biochemical Journal 396, no. 2 (May 15, 2006): 219–26. http://dx.doi.org/10.1042/bj20060108.
Повний текст джерелаLiu, Hongmei, Xiaoyun Wu, Hongling Xiao, and John C. Kappes. "Targeting Human Immunodeficiency Virus (HIV) Type 2 Integrase Protein into HIV Type 1." Journal of Virology 73, no. 10 (October 1, 1999): 8831–36. http://dx.doi.org/10.1128/jvi.73.10.8831-8836.1999.
Повний текст джерелаElalouf, Amir. "In-silico Structural Modeling of Human Immunodeficiency Virus Proteins." Biomedical Engineering and Computational Biology 14 (January 2023): 117959722311544. http://dx.doi.org/10.1177/11795972231154402.
Повний текст джерелаCoghlan, Andy. "Virus-sabotaging protein may help people defy HIV." New Scientist 220, no. 2940 (October 2013): 19. http://dx.doi.org/10.1016/s0262-4079(13)62520-8.
Повний текст джерелаTang, Yao, Ulrike Winkler, Eric O. Freed, Ted A. Torrey, Wankee Kim, Henry Li, Stephen P. Goff, and Herbert C. Morse. "Cellular Motor Protein KIF-4 Associates with Retroviral Gag." Journal of Virology 73, no. 12 (December 1, 1999): 10508–13. http://dx.doi.org/10.1128/jvi.73.12.10508-10513.1999.
Повний текст джерелаNoble, Beth, Paolo Abada, Juan Nunez-Iglesias, and Paula M. Cannon. "Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release." Journal of Virology 80, no. 6 (March 15, 2006): 2924–32. http://dx.doi.org/10.1128/jvi.80.6.2924-2932.2006.
Повний текст джерелаFackler, Oliver T., Paola d'Aloja, Andreas S. Baur, Maurizio Federico, and B. Matija Peterlin. "Nef from Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and Infectivity." Journal of Virology 75, no. 14 (July 15, 2001): 6601–8. http://dx.doi.org/10.1128/jvi.75.14.6601-6608.2001.
Повний текст джерелаMeschi, Joseph, Erika C. Crouch, Paul Skolnik, Khabirah Yahya, Uffe Holmskov, Rikke Leth-Larsen, Ida Tornoe, Tesfaldet Tecle, Mitchell R. White, and Kevan L. Hartshorn. "Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication." Journal of General Virology 86, no. 11 (November 1, 2005): 3097–107. http://dx.doi.org/10.1099/vir.0.80764-0.
Повний текст джерелаVillet, Stéphanie, Baya Amel Bouzar, Thierry Morin, Gérard Verdier, Catherine Legras, and Yahia Chebloune. "Maedi-Visna Virus and Caprine Arthritis Encephalitis Virus Genomes Encode a Vpr-Like but No Tat Protein." Journal of Virology 77, no. 17 (September 1, 2003): 9632–38. http://dx.doi.org/10.1128/jvi.77.17.9632-9638.2003.
Повний текст джерелаConti, Lucia, Barbara Varano, M. Cristina Gauzzi, Paola Matarrese, Maurizio Federico, Walter Malorni, Filippo Belardelli, and Sandra Gessani. "Impairment of Human Immunodeficiency Virus Type 1 (HIV-1) Entry into Jurkat T Cells by Constitutive Expression of the HIV-1 Vpr Protein: Role of CD4 Down-Modulation." Journal of Virology 74, no. 21 (November 1, 2000): 10207–11. http://dx.doi.org/10.1128/jvi.74.21.10207-10211.2000.
Повний текст джерелаAbada, Paolo, Beth Noble, and Paula M. Cannon. "Functional Domains within the Human Immunodeficiency Virus Type 2 Envelope Protein Required To Enhance Virus Production." Journal of Virology 79, no. 6 (March 15, 2005): 3627–38. http://dx.doi.org/10.1128/jvi.79.6.3627-3638.2005.
Повний текст джерелаChan, Eric Y., Jennifer N. Sutton, Jon M. Jacobs, Andrey Bondarenko, Richard D. Smith, and Michael G. Katze. "Dynamic Host Energetics and Cytoskeletal Proteomes in Human Immunodeficiency Virus Type 1-Infected Human Primary CD4 Cells: Analysis by Multiplexed Label-Free Mass Spectrometry." Journal of Virology 83, no. 18 (July 8, 2009): 9283–95. http://dx.doi.org/10.1128/jvi.00814-09.
Повний текст джерелаWang, Bao-Zhong, Weimin Liu, Sang-Moo Kang, Munir Alam, Chunzi Huang, Ling Ye, Yuliang Sun, et al. "Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles." Journal of Virology 81, no. 20 (August 1, 2007): 10869–78. http://dx.doi.org/10.1128/jvi.00542-07.
Повний текст джерелаAlatortseva, G. I., M. N. Nosik, L. N. Nesterenko, I. I. Amiantova, V. V. Dotsenko, L. N. Luhverchik, M. V. Zhuckina, V. U. Kabargina, E. N. Kudryavtseva, and V. V. Zverev. "Study of Antigenic properties of Human immunodeficiency Virus NEF protein Recombinant Analog." Epidemiology and Vaccine Prevention 15, no. 3 (June 20, 2016): 83–93. http://dx.doi.org/10.31631/2073-3046-2016-15-3-83-93.
Повний текст джерелаGriffin, Stephen D. C., Jane F. Allen, and Andrew M. L. Lever. "The Major Human Immunodeficiency Virus Type 2 (HIV-2) Packaging Signal Is Present on All HIV-2 RNA Species: Cotranslational RNA Encapsidation and Limitation of Gag Protein Confer Specificity." Journal of Virology 75, no. 24 (December 15, 2001): 12058–69. http://dx.doi.org/10.1128/jvi.75.24.12058-12069.2001.
Повний текст джерелаChazal, Nathalie, Gregory Singer, Christopher Aiken, Marie-Louise Hammarskjöld, and David Rekosh. "Human Immunodeficiency Virus Type 1 Particles Pseudotyped with Envelope Proteins That Fuse at Low pH No Longer Require Nef for Optimal Infectivity." Journal of Virology 75, no. 8 (April 15, 2001): 4014–18. http://dx.doi.org/10.1128/jvi.75.8.4014-4018.2001.
Повний текст джерелаCopeland, K. M., A. J. Elliot, and R. S. Daniels. "Functional Chimeras of Human Immunodeficiency Virus Type 1 gp120 and Influenza A Virus (H3) Hemagglutinin." Journal of Virology 79, no. 10 (May 15, 2005): 6459–71. http://dx.doi.org/10.1128/jvi.79.10.6459-6471.2005.
Повний текст джерелаFeng, Feng, Adam Davis, Julie-Anne Lake, Jill Carr, Wei Xia, Christopher Burrell, and Peng Li. "Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif." Journal of Virology 78, no. 19 (October 1, 2004): 10574–81. http://dx.doi.org/10.1128/jvi.78.19.10574-10581.2004.
Повний текст джерелаStevens, Miguel, Christophe Pannecouque, Erik De Clercq, and Jan Balzarini. "Novel Human Immunodeficiency Virus (HIV) Inhibitors That Have a Dual Mode of Anti-HIV Action." Antimicrobial Agents and Chemotherapy 47, no. 10 (October 2003): 3109–16. http://dx.doi.org/10.1128/aac.47.10.3109-3116.2003.
Повний текст джерелаEwart, Gary D., Najla Nasr, Hassan Naif, Graeme B. Cox, Anthony L. Cunningham, and Peter W. Gage. "Potential New Anti-Human Immunodeficiency Virus Type 1 Compounds Depress Virus Replication in Cultured Human Macrophages." Antimicrobial Agents and Chemotherapy 48, no. 6 (June 2004): 2325–30. http://dx.doi.org/10.1128/aac.48.6.2325-2330.2004.
Повний текст джерелаMurakami, Hironobu, Takehiro Suzuki, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Manabu Taura, Eriko Kudo, Seiji Okada, et al. "Protein Arginine N-methyltransferases 5 and 7 Promote HIV-1 Production." Viruses 12, no. 3 (March 23, 2020): 355. http://dx.doi.org/10.3390/v12030355.
Повний текст джерелаMete, Bilgül, Emre Pekbilir, Bilge Nur Bilge, Panagiota Georgiadou, Elif Çelik, Tolga Sutlu, Fehmi Tabak, and Umut Sahin. "Human immunodeficiency virus type 1 impairs sumoylation." Life Science Alliance 5, no. 6 (February 18, 2022): e202101103. http://dx.doi.org/10.26508/lsa.202101103.
Повний текст джерелаPadow, Marcus, Lilin Lai, Champion Deivanayagam, Lawrence J. DeLucas, Robert B. Weiss, Diane M. Dunn, Xiaoyun Wu, and John C. Kappes. "Replication of Chimeric Human Immunodeficiency Virus Type 1 (HIV-1) Containing HIV-2 Integrase (IN): Naturally Selected Mutations in IN Augment DNA Synthesis." Journal of Virology 77, no. 20 (October 15, 2003): 11050–59. http://dx.doi.org/10.1128/jvi.77.20.11050-11059.2003.
Повний текст джерелаZhou, Jing, and Christopher Aiken. "Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity Resulting from Intervirion Fusion: Evidence Supporting a Role for Nef at the Virion Envelope." Journal of Virology 75, no. 13 (July 1, 2001): 5851–59. http://dx.doi.org/10.1128/jvi.75.13.5851-5859.2001.
Повний текст джерелаMcLinden, James H., Jack T. Stapleton, Donna Klinzman, Krishna K. Murthy, Qing Chang, Thomas M. Kaufman, Nirjal Bhattarai, and Jinhua Xiang. "Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4+ T-cells." Journal of General Virology 94, no. 4 (April 1, 2013): 774–82. http://dx.doi.org/10.1099/vir.0.047126-0.
Повний текст джерелаAli, Amjad, Rameez Raja, Sabihur Rahman Farooqui, Shaista Ahmad, and Akhil C. Banerjea. "USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein." Biochemical Journal 474, no. 10 (May 4, 2017): 1653–68. http://dx.doi.org/10.1042/bcj20160304.
Повний текст джерелаEspert, Lucile, Geneviève Degols, Yea-Lih Lin, Thierry Vincent, Monsef Benkirane, and Nadir Mechti. "Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1." Journal of General Virology 86, no. 8 (August 1, 2005): 2221–29. http://dx.doi.org/10.1099/vir.0.81074-0.
Повний текст джерелаAgrawal, Lokesh, Qingwen Jin, Jeff Altenburg, L. Meyer, R. Tubiana, Ioannis Theodorou та Ghalib Alkhatib. "CCR5Δ32 Protein Expression and Stability Are Critical for Resistance to Human Immunodeficiency Virus Type 1 In Vivo". Journal of Virology 81, № 15 (23 травня 2007): 8041–49. http://dx.doi.org/10.1128/jvi.00068-07.
Повний текст джерелаKotov, Alexander, Jing Zhou, Paula Flicker, and Christopher Aiken. "Association of Nef with the Human Immunodeficiency Virus Type 1 Core." Journal of Virology 73, no. 10 (October 1, 1999): 8824–30. http://dx.doi.org/10.1128/jvi.73.10.8824-8830.1999.
Повний текст джерелаMcGettigan, James P., Satyam Sarma, Jan M. Orenstein, Roger J. Pomerantz, and Matthias J. Schnell. "Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector." Journal of Virology 75, no. 18 (September 15, 2001): 8724–32. http://dx.doi.org/10.1128/jvi.75.18.8724-8732.2001.
Повний текст джерелаGordón-Alonso, Mónica, Vera Rocha-Perugini, Susana Álvarez, Olga Moreno-Gonzalo, Ángeles Ursa, Soraya López-Martín, Nuria Izquierdo-Useros, et al. "The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry." Molecular Biology of the Cell 23, no. 12 (June 15, 2012): 2253–63. http://dx.doi.org/10.1091/mbc.e11-12-1003.
Повний текст джерелаYu, Jae-Sung, James W. Peacock, Stacie Vanleeuwen, Tsungda Hsu, William R. Jacobs, Mark J. Cayabyab, Norman L. Letvin, et al. "Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis▿." Clinical and Vaccine Immunology 13, no. 11 (August 30, 2006): 1204–11. http://dx.doi.org/10.1128/cvi.00195-06.
Повний текст джерелаSakalian, Michael, Stephanie S. Dittmer, A. Dustin Gandy, Nathan D. Rapp, Aleš Zábranský, and Eric Hunter. "The Mason-Pfizer Monkey Virus Internal Scaffold Domain Enables In Vitro Assembly of Human Immunodeficiency Virus Type 1 Gag." Journal of Virology 76, no. 21 (November 1, 2002): 10811–20. http://dx.doi.org/10.1128/jvi.76.21.10811-10820.2002.
Повний текст джерелаContarino, Mark, Arangassery R. Bastian, Ramalingam Venkat Kalyana Sundaram, Karyn McFadden, Caitlin Duffy, Vamshi Gangupomu, Michelle Baker, Cameron Abrams, and Irwin Chaiken. "Chimeric Cyanovirin-MPER Recombinantly Engineered Proteins Cause Cell-Free Virolysis of HIV-1." Antimicrobial Agents and Chemotherapy 57, no. 10 (July 15, 2013): 4743–50. http://dx.doi.org/10.1128/aac.00309-13.
Повний текст джерелаHatanaka, Hideki, Oleg Iourin, Zihe Rao, Elizabeth Fry, Alan Kingsman, and David I. Stuart. "Structure of Equine Infectious Anemia Virus Matrix Protein." Journal of Virology 76, no. 4 (February 15, 2002): 1876–83. http://dx.doi.org/10.1128/jvi.76.4.1876-1883.2002.
Повний текст джерелаSoper, Andrew, Guillermo Juarez-Fernandez, Hirofumi Aso, Miyu Moriwaki, Eri Yamada, Yusuke Nakano, Yoshio Koyanagi, and Kei Sato. "Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication." Experimental Biology and Medicine 242, no. 8 (February 28, 2017): 850–58. http://dx.doi.org/10.1177/1535370217697384.
Повний текст джерелаTuffy, Kevin M., Rebecca J. Kaddis Maldonado, Jordan Chang, Paul Rosenfeld, Alan Cochrane, and Leslie J. Parent. "HIV-1 Gag Forms Ribonucleoprotein Complexes with Unspliced Viral RNA at Transcription Sites." Viruses 12, no. 11 (November 9, 2020): 1281. http://dx.doi.org/10.3390/v12111281.
Повний текст джерелаKomano, Jun, Kosuke Miyauchi, Zene Matsuda, and Naoki Yamamoto. "Inhibiting the Arp2/3 Complex Limits Infection of Both Intracellular Mature Vaccinia Virus and Primate Lentiviruses." Molecular Biology of the Cell 15, no. 12 (December 2004): 5197–207. http://dx.doi.org/10.1091/mbc.e04-04-0279.
Повний текст джерелаGurer, Cagan, Lionel Berthoux, and Jeremy Luban. "Covalent Modification of Human Immunodeficiency Virus Type 1 p6 by SUMO-1." Journal of Virology 79, no. 2 (January 15, 2005): 910–17. http://dx.doi.org/10.1128/jvi.79.2.910-917.2005.
Повний текст джерелаWong, G. H., J. F. Krowka, D. P. Stites, and D. V. Goeddel. "In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma." Journal of Immunology 140, no. 1 (January 1, 1988): 120–24. http://dx.doi.org/10.4049/jimmunol.140.1.120.
Повний текст джерелаMcGettigan, James P., Heather D. Foley, Igor M. Belyakov, Jay A. Berzofsky, Roger J. Pomerantz, and Matthias J. Schnell. "Rabies Virus-Based Vectors Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Protein Induce a Strong, Cross-Reactive Cytotoxic T-Lymphocyte Response against Envelope Proteins from Different HIV-1 Isolates." Journal of Virology 75, no. 9 (May 1, 2001): 4430–34. http://dx.doi.org/10.1128/jvi.75.9.4430-4434.2001.
Повний текст джерелаZhou, Yongdong, Liwei Rong, Jennifer Lu, Qinghua Pan, and Chen Liang. "Insulin-Like Growth Factor II mRNA Binding Protein 1 Associates with Gag Protein of Human Immunodeficiency Virus Type 1, and Its Overexpression Affects Virus Assembly." Journal of Virology 82, no. 12 (April 2, 2008): 5683–92. http://dx.doi.org/10.1128/jvi.00189-08.
Повний текст джерелаOjo-Amaize, E. A., P. Nishanian, D. E. Keith, R. L. Houghton, D. F. Heitjan, J. L. Fahey, and J. V. Giorgi. "Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells." Journal of Immunology 139, no. 7 (October 1, 1987): 2458–63. http://dx.doi.org/10.4049/jimmunol.139.7.2458.
Повний текст джерелаClerzius, Guerline, Jean-François Gélinas, Aïcha Daher, Marion Bonnet, Eliane F. Meurs, and Anne Gatignol. "ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication." Journal of Virology 83, no. 19 (July 15, 2009): 10119–28. http://dx.doi.org/10.1128/jvi.02457-08.
Повний текст джерелаKrishnan, Lavanya, Kenneth A. Matreyek, Ilker Oztop, Kyeongeun Lee, Christopher H. Tipper, Xiang Li, Mohd J. Dar, Vineet N. KewalRamani, and Alan Engelman. "The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) during Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase." Journal of Virology 84, no. 1 (October 21, 2009): 397–406. http://dx.doi.org/10.1128/jvi.01899-09.
Повний текст джерелаPontzer, C. H., J. K. Yamamoto, F. W. Bazer, T. L. Ott, and H. M. Johnson. "Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau." Journal of Immunology 158, no. 9 (May 1, 1997): 4351–57. http://dx.doi.org/10.4049/jimmunol.158.9.4351.
Повний текст джерелаBennett, Erin M., Andrew M. L. Lever, and Jane F. Allen. "Human Immunodeficiency Virus Type 2 Gag Interacts Specifically with PRP4, a Serine-Threonine Kinase, and Inhibits Phosphorylation of Splicing Factor SF2." Journal of Virology 78, no. 20 (October 15, 2004): 11303–12. http://dx.doi.org/10.1128/jvi.78.20.11303-11312.2004.
Повний текст джерелаParveen, Zahida, Muhammad Mukhtar, Adrienne Goodrich, Edward Acheampong, Ralph Dornburg, and Roger J. Pomerantz. "Cross-Packaging of Human Immunodeficiency Virus Type 1 Vector RNA by Spleen Necrosis Virus Proteins: Construction of a New Generation of Spleen Necrosis Virus-Derived Retroviral Vectors." Journal of Virology 78, no. 12 (June 15, 2004): 6480–88. http://dx.doi.org/10.1128/jvi.78.12.6480-6488.2004.
Повний текст джерела